Literature DB >> 22868377

Innate immune responses in hepatitis C virus infection.

Kui Li1, Stanley M Lemon.   

Abstract

Hepatitis C virus (HCV) is a major causative agent of chronic hepatitis and hepatocellular carcinoma worldwide and thus poses a significant public health threat. A hallmark of HCV infection is the extraordinary ability of the virus to persist in a majority of infected people. Innate immune responses represent the front line of defense of the human body against HCV immediately after infection. They also play a crucial role in orchestrating subsequent HCV-specific adaptive immunity that is pivotal for viral clearance. Accumulating evidence suggests that the host has evolved multifaceted innate immune mechanisms to sense HCV infection and elicit defense responses, while HCV has developed elaborate strategies to circumvent many of these. Defining the interplay of HCV with host innate immunity reveals mechanistic insights into hepatitis C pathogenesis and informs approaches to therapy. In this review, we summarize recent advances in understanding innate immune responses to HCV infection, focusing on induction and effector mechanisms of the interferon antiviral response as well as the evasion strategies of HCV.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22868377      PMCID: PMC3732459          DOI: 10.1007/s00281-012-0332-x

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  186 in total

Review 1.  Toll-like receptor and RIG-I-like receptor signaling.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

2.  Ultrastructural and biochemical analyses of hepatitis C virus-associated host cell membranes.

Authors:  Pauline Ferraris; Emmanuelle Blanchard; Philippe Roingeard
Journal:  J Gen Virol       Date:  2010-05-19       Impact factor: 3.891

3.  Activation of anti-hepatitis C virus responses via Toll-like receptor 7.

Authors:  Jongdae Lee; Christina C N Wu; Ki Jeong Lee; Tsung-Hsien Chuang; Kyoko Katakura; Yu-Tsueng Liu; Michael Chan; Rommel Tawatao; Michelle Chung; Carol Shen; Howard B Cottam; Michael M C Lai; Eyal Raz; Dennis A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-30       Impact factor: 11.205

4.  Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli.

Authors:  Pamela A Carpentier; Bryan R Williams; Stephen D Miller
Journal:  Glia       Date:  2007-02       Impact factor: 7.452

5.  Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses.

Authors:  Thiagarajan Venkataraman; Maikel Valdes; Rachel Elsby; Shigeru Kakuta; Gisela Caceres; Shinobu Saijo; Yoichiro Iwakura; Glen N Barber
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

6.  Toll-like receptor 3 mediates establishment of an antiviral state against hepatitis C virus in hepatoma cells.

Authors:  Nan Wang; Yuqiong Liang; Santhana Devaraj; Jie Wang; Stanley M Lemon; Kui Li
Journal:  J Virol       Date:  2009-07-22       Impact factor: 5.103

7.  Hepatitis C virus genotype 1a growth and induction of autophagy.

Authors:  Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S Ryerse; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

8.  Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.

Authors:  Jin-Hai Chang; Naoya Kato; Ryosuke Muroyama; Hiroyoshi Taniguchi; Bayasi Guleng; Narayan Dharel; Run-Xuan Shao; Keisuke Tateishi; Amarsanaa Jazag; Takao Kawabe; Masao Omata
Journal:  Liver Int       Date:  2009-10-16       Impact factor: 5.828

9.  Interferon modulation of cellular microRNAs as an antiviral mechanism.

Authors:  Irene M Pedersen; Guofeng Cheng; Stefan Wieland; Stefano Volinia; Carlo M Croce; Francis V Chisari; Michael David
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

Review 10.  Hepatitis C pathogenesis: mechanisms of viral clearance and liver injury.

Authors:  Hugo R Rosen
Journal:  Liver Transpl       Date:  2003-11       Impact factor: 5.799

View more
  43 in total

Review 1.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

Review 2.  Viruses and human cancers: a long road of discovery of molecular paradigms.

Authors:  Martyn K White; Joseph S Pagano; Kamel Khalili
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Strategies Targeting the Innate Immune Response for the Treatment of Hepatitis C Virus-Associated Liver Fibrosis.

Authors:  Daniel Sepulveda-Crespo; Salvador Resino; Isidoro Martinez
Journal:  Drugs       Date:  2021-01-05       Impact factor: 9.546

4.  A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha-Inducible Protein 6.

Authors:  Xiao Liu; Xiaoqiong Duan; Jacinta A Holmes; Wenting Li; Sae Hwan Lee; Zeng Tu; Chuanlong Zhu; Shadi Salloum; Anna Lidofsky; Esperance A Schaefer; Dachuan Cai; Shilin Li; Haoju Wang; Yongfu Huang; Yongju Zhao; Ming-Lung Yu; Zhiwen Xu; Limin Chen; Jian Hong; Wenyu Lin; Raymond T Chung
Journal:  Hepatology       Date:  2019-02-13       Impact factor: 17.425

Review 5.  The Strange, Expanding World of Animal Hepaciviruses.

Authors:  Alex S Hartlage; John M Cullen; Amit Kapoor
Journal:  Annu Rev Virol       Date:  2016-09-29       Impact factor: 10.431

Review 6.  Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?

Authors:  Da-Rong Yang; Hai-Zhen Zhu
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

7.  Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use.

Authors:  Martin Markowitz; Sherry Deren; Charles Cleland; Melissa La Mar; Evelyn Silva; Pedro Batista; Leslie St Bernard; Natanya Gettie; Kristina Rodriguez; Teresa H Evering; Haekyung Lee; Saurabh Mehandru
Journal:  J Infect Dis       Date:  2016-08-11       Impact factor: 5.226

Review 8.  Progress in the development of vaccines for hepatitis C virus infection.

Authors:  Faezeh Ghasemi; Sina Rostami; Zahra Meshkat
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

9.  Viral persistence, liver disease, and host response in a hepatitis C-like virus rat model.

Authors:  Sheetal Trivedi; Satyapramod Murthy; Himanshu Sharma; Alex S Hartlage; Arvind Kumar; Sashi V Gadi; Peter Simmonds; Lokendra V Chauhan; Troels K H Scheel; Eva Billerbeck; Peter D Burbelo; Charles M Rice; W Ian Lipkin; Kurt Vandegrift; John M Cullen; Amit Kapoor
Journal:  Hepatology       Date:  2018-05-21       Impact factor: 17.425

10.  Acetaldehyde accelerates HCV-induced impairment of innate immunity by suppressing methylation reactions in liver cells.

Authors:  Murali Ganesan; Jinjin Zhang; Tatiana Bronich; Larisa I Poluektova; Terrence M Donohue; Dean J Tuma; Kusum K Kharbanda; Natalia A Osna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.